Similar articles

• [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].

  Raevskiĭ KS. Raevskiĭ KS. Farmakol Toksikol. 1973 Mar-Apr;36(2):149-54. Farmakol Toksikol. 1973. PMID: 4151668 Russian. No abstract available.
• Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

  Andén NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Andén NE, et al. Eur J Pharmacol. 1970;11(3):303-14. doi: 10.1016/0014-2999(70)90006-3. Eur J Pharmacol. 1970. PMID: 5477307 No abstract available.
• Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

  Matthysse S. Matthysse S. Fed Proc. 1973 Feb;32(2):200-5. Fed Proc. 1973. PMID: 4348519 Review. No abstract available.
• Psychoactive drugs and brain neurochemical transmitters.

  Valzelli L. Valzelli L. Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:221+. Arch Int Pharmacodyn Ther. 1972. PMID: 4342945 Review. No abstract available.
• Effect of drugs used in psychoses on cerebral dopamine metabolism.

  O'Keeffe R, Sharman DF, Vogt M. O'Keeffe R, et al. Br J Pharmacol. 1970 Feb;38(2):287-304. doi: 10.1111/j.1476-5381.1970.tb08517.x. Br J Pharmacol. 1970. PMID: 4984801 Free PMC article.